The cardiovascular safety of this dose of semaglutide is currently being evaluated in the SELECT trial, where 17,500 individuals with obesity and established CVD are randomised to semaglutide or placebo for 2.5-5 years
They're probably going to gain it back, you know, so that is one thing that uniquely we have um In our, you know repertoire of services We are expanding our program nationwide under modern weight loss as a new brand that launches next month Those people will not have perfect thyroid function, you know, and so i'm curious to see how the data pans out with them But we really use this time to get habits in order to develop good lifestyle, you know, systems, put that in place, really show metabolic sensitivity
No memberships, no contracts, no hidden fees, and you can cancel anytime
The potential risks of using Semaglutide while breastfeeding include the uncertainty of its effects on breastfed infants due to minimal available data